Sage Journals: Discover world-class research

Retricted access

Research article

First published 2011-8

Regulatory divergence

Alasdair Breckenridge

Clinical Trials

Retricted access

Other

First published 2005-03

Regulatory Capitalism: Policy Irritants and Convergent Divergence

David Levi-Faur, Jacint Jordana

The ANNALS of the American Academy of Political and Social Science

Retricted access

Research article

First published 2025-11

Regulatory Mandates and Gender Diversity in Corporate Boards: The Family Firm Effect

Nupur Pavan Bang, Raveendra Chittoor, Kavil Ramachandran

The Journal of Entrepreneurship

Free access

Research article

First published 2012-2

Regulatory T-Cells: Diverse Phenotypes Integral to Immune Homeostasis and Suppression

Richard A. Peterson

Toxicologic Pathology

Retricted access

Research article

First published 1991-10

Follistatin and Activin: A Potential Intrinsic Regulatory System within Diverse Tissues

Louis V. DePaolo, Thomas A. Bicsak, Gregory F. Erickson [...]

Experimental Biology and Medicine

Open access

Review article

First published 2019-7

Circular RNAs: Diversity of Functions and a Regulatory Nova in Oral Medicine: A Pilot Review

Hong Wang, Cheng Feng, Meng Wang [...]

Cell Transplantation

Retricted access

Research article

First published 2012-12

The role of regulatory and temporal context in the construction of diversity discourses: The case of the UK,France and Germany

Ahu Tatli, Joana Vassilopoulou, Akram Al Ariss [...]

European Journal of Industrial Relations

Open access

Research article

First published 2026-1

Joint Data Responsibility in Global Digital Trade: A Meso-Level Comparative Analysis of the European Union,the United States,and China

Yifan Guo

Sage Open

Retricted access

Research article

First published 2005-07

PKC Sulfhydryl Targeting by Disulfiram Produces Divergent Isozymic Regulatory Responses that Accord with the Cancer Preventive Activity of the Thiuram Disulfide

Feng Chu, Catherine A. O'Brian

Antioxidants & Redox Signaling

Free access

Editorial

First published 2010-08

The divergent opinions of regulatory authorities on roflumilast are puzzling but we need new drugs for treating chronic obstructive pulmonary disease

Mario Cazzola

Therapeutic Advances in Respiratory Disease

Search results